Explore the challenges and successes epilepsy centers face in implementing the newly expanded NAEC guidelines, particularly regarding mental health screenings and multidisciplinary care.
Explore the challenges and successes epilepsy centers face in implementing the newly expanded NAEC guidelines, particularly regarding mental health screenings and multidisciplinary care.
Discover how the new 2023 Guidelines for epilepsy centers highlight comprehensive care and the pivotal role of genetic testing in addressing health disparities and improving patient outcomes.
Discover how the new 2023 Guidelines for epilepsy centers highlight comprehensive care and the pivotal role of genetic testing in addressing health disparities and improving patient outcomes.
Dr Ivanhoe examines why she doesn't typically use oral medications for patients with spasticity, how to naviagate effective communication between clinician and patient, exciting new treatments on the horizon, and how not to lose "that human...
Dr Ivanhoe examines why she doesn't typically use oral medications for patients with spasticity, how to naviagate effective communication between clinician and patient, exciting new treatments on the horizon, and how not to lose "that human...
Dr Ivanhoe discusses everything from treatment variations between pediatric and adult patients to botulinum neurotoxin use and the nuanced factors influencing candidate selection to the profound impact of untreated spasticity on long-term...
Dr Ivanhoe discusses everything from treatment variations between pediatric and adult patients to botulinum neurotoxin use and the nuanced factors influencing candidate selection to the profound impact of untreated spasticity on long-term...
In Part 2 of this Q&A, Scott Otallah, MD, describes some of the challenges providers can expect to face when treating MS in pediatric patients as well as trends to keep an eye on in the near future.
In Part 2 of this Q&A, Scott Otallah, MD, describes some of the challenges providers can expect to face when treating MS in pediatric patients as well as trends to keep an eye on in the near future.
Findings from a large Aspirin in Reducing Events in the Elderly (ASPREE) cohort suggest cognitive changes could serve as early indicators of cardiovascular risk.
Findings from a large Aspirin in Reducing Events in the Elderly (ASPREE) cohort suggest cognitive changes could serve as early indicators of cardiovascular risk.
The addition of endovascular treatment (EVT) to best medical treatment (BMT) was associated with a higher likelihood of achieving good imaging outcomes compared with BMT alone in patients with a medium or distal vessel occlusion stroke.
The addition of endovascular treatment (EVT) to best medical treatment (BMT) was associated with a higher likelihood of achieving good imaging outcomes compared with BMT alone in patients with a medium or distal vessel occlusion stroke.
Real-world data presented at the American Academy of Neurology (AAN) 2026 Annual Meeting reported improvements in migraine-related cognitive symptoms with eptinezumab (VYEPTI).
Real-world data presented at the American Academy of Neurology (AAN) 2026 Annual Meeting reported improvements in migraine-related cognitive symptoms with eptinezumab (VYEPTI).
Teleneurological ward rounds were found noninferior to conventional on-site ward rounds in subacute inpatient stroke care, according to prospective study findings.
Teleneurological ward rounds were found noninferior to conventional on-site ward rounds in subacute inpatient stroke care, according to prospective study findings.
High-dose influenza vaccination may confer additional neuroprotective benefit beyond standard-dose formulations, according to results from a new, large retrospective cohort study published in Neurology.
High-dose influenza vaccination may confer additional neuroprotective benefit beyond standard-dose formulations, according to results from a new, large retrospective cohort study published in Neurology.
According to recent findings, early extubation after thrombectomy did not improve 90-day functional independence compared with delayed extubation in patients with acute ischemic stroke.
According to recent findings, early extubation after thrombectomy did not improve 90-day functional independence compared with delayed extubation in patients with acute ischemic stroke.
A phase 3 clinical trial found that tavapadon, an investigational oral D1/D5 dopamine agonist, was effective as an adjunctive therapy to levodopa for motor fluctuations in Parkinson disease (PD).
A phase 3 clinical trial found that tavapadon, an investigational oral D1/D5 dopamine agonist, was effective as an adjunctive therapy to levodopa for motor fluctuations in Parkinson disease (PD).
A prospective cohort study found that suicidality at the time of focal epilepsy diagnosis was linked to a more than twofold increased risk of future antiseizure medication (ASM) treatment resistance.
A prospective cohort study found that suicidality at the time of focal epilepsy diagnosis was linked to a more than twofold increased risk of future antiseizure medication (ASM) treatment resistance.
Patients with migraine are at 2 times the risk for depression or anxiety compared to those without migraine, according to a large nationwide Swedish cohort study published in The Journal of Headache and Pain.
Patients with migraine are at 2 times the risk for depression or anxiety compared to those without migraine, according to a large nationwide Swedish cohort study published in The Journal of Headache and Pain.
The pivotal Phase III FENhance 1 trial of fenebrutinib met its primary endpoint in relapsing multiple sclerosis (RMS), demonstrating statistically significant and clinically meaningful reductions in relapse activity.
The pivotal Phase III FENhance 1 trial of fenebrutinib met its primary endpoint in relapsing multiple sclerosis (RMS), demonstrating statistically significant and clinically meaningful reductions in relapse activity.
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data
To view accreditation information/faculty disclosures for the program, click
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data
To view accreditation information/faculty disclosures for the program, click
